e-learning
resources
Stockholm 2007
Monday 17.09.2007
Towards controlling severe asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Safety of formoterol in asthma trials
M. Sears, A. Ottosson, F. Radner, S. Suissa (Hamilton, ON, Montreal, QC, Canada; Lund, Sweden)
Source:
Annual Congress 2007 - Towards controlling severe asthma
Session:
Towards controlling severe asthma
Session type:
Oral Presentation
Number:
1586
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Sears, A. Ottosson, F. Radner, S. Suissa (Hamilton, ON, Montreal, QC, Canada; Lund, Sweden). Safety of formoterol in asthma trials. Eur Respir J 2007; 30: Suppl. 51, 1586
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Safety of formoterol in asthma clinical trials
Source: Annual Congress 2012 - Asthma treatment: efficacy and safety
Year: 2012
Safety of formoterol in asthma clinical trials: an update
Source: Eur Respir J 2014; 43: 103-114
Year: 2004
Safety of as-needed formoterol in asthma patients on different maintenance long-acting ß2-agonists
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021
Safety and tolerability of high-dose formoterol
via
aerolizer and salbutamol via MDI in patients with mild-to-moderate COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 285s
Year: 2003
Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008
Efficacy and tolerability of formoterol Turbuhaler in 6–11 year old children with asthma, not adequately controlled with inhaled corticosteroids
Source: Eur Respir J 2002; 20: Suppl. 38, 430s
Year: 2002
Safety of long-acting β-agonist (LABA) withdrawal in patients in two clinical asthma trials
Source: Annual Congress 2012 - Different ways to phenotype asthma
Year: 2012
Safety of formoterol in children and adolescents: experience from asthma clinical trials
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008
Safety of formoterol by Turbuhaler(R) as reliever medication compared with terbutaline in moderate asthma
Source: Eur Respir J 2002; 20: 859-866
Year: 2002
Efficacy of once-daily tiotropium Respimat in adults with asthma based on GINA Steps 2–5
Source: International Congress 2017 – Bronchial asthma management
Year: 2017
Long-acting β-agonists: a review of formoterol safety data from asthma clinical trials
Source: Eur Respir J 2009; 33: 21-32
Year: 2009
1-year efficacy and safety study of tiotropium respimat add-on to ICS in adolescent patients with symptomatic asthma
Source: International Congress 2014 – Bronchodilators for asthma and COPD
Year: 2014
Cost-effectiveness of formoterol turbuhaler versus salbutamol as reliever therapy in asthma: results from the RELIEF worldwide randomised effectiveness study
Source: Eur Respir J 2002; 20: Suppl. 38, 43s
Year: 2002
Bronchodilator therapy with indacaterol once-daily in COPD: a 52-week comparison with formoterol
Source: Annual Congress 2009 - Next generation bronchodilators
Year: 2009
Safety and tolerability of indacaterol once-daily in COPD patients versus placebo and tiotropium: a 26-week study
Source: Annual Congress 2009 - New bronchodilators
Year: 2009
Efficacy and safety of budesonide/formoterol comparing with budesonide and theophylline in Japanese adult patients with asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008
Long-term safety of inhaled formoterol in patients with COPD
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Device preference and efficacy of formoterol aerolizer and salbutamol MDI in children with asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 134s
Year: 2003
Long-term safety of inhaled formoterol in adult asthma patients
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009
24-h efficacy and pharmacokinetics of tiotropium Respimat® 5 μg in patients with asthma
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept